Task 2 one-way ANCOVA significant results. حسب Mucahit Gemici (21519313)

DALY and HLY in Portugal, 1990–2019. The first graph shows a decreasing trend of DALY and the second graph shows an increasing trend of HLY. حسب Aida Isabel Tavares (12080156)

Summary of significant single-arm time effect. حسب Wensheng Xiao (16557866)

<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. حسب Siyun Lee (17087351)

Average mean decrease Gini across 100 partitions for the top 10 most important variables for binary mixed model and random forest. حسب Helal El-Zaatari (20442243)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count. حسب Francesca Catto (21253435)

Analysis of the Nugent score before (T=0) and after (T=1) the use of the vaginal gel. Number of participants and respective percentages of Nugent scores before and after the interv... حسب Adriana Bittencourt Campaner (21175462)

<b>Manure improves temperature sensitivity of soil organic carbon by increasing soil alphaproteobacteria, phenols, and pH and decreasing soil esters</b> حسب Andong Cai (5237024)

Thymus regeneration promotes naïve T-cell recovery in iMycTg aging-E mice and a partial decrease in Treg frequencies. حسب Abigail Morales-Sánchez (21799582)

Significant associations in GWAS. حسب Dai Nogimura (21445649)

"…<div><p>Decreased nitric oxide (NO) production from the vascular endothelium is a major factor for vascular aging. …"

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. حسب Francesca Catto (21253435)

Enrichment analysis of genes from the significant MS module. حسب Lai Jiang (2401513)

الموضوعات:

Deletion of C3 and C3aR reversed <i>S. aureus</i>-induced decrease in synapse density and increase in microglial phagocytosis of synapses. حسب Haifang Zhang (314544)

P values of Kruskal–Wallis test at 95% significance level. حسب Fahd Saeed Alakbari (10701871)

الموضوعات:

Summary of post-treatment disease course measures from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات:

Study selection criteria. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. حسب Filip Stanicic (17808254)

الموضوعات:

Disease course measures after the PTSD treatments. حسب Filip Stanicic (17808254)

الموضوعات:

PICOS criteria for the SLR. حسب Filip Stanicic (17808254)

الموضوعات:

Summary of post-treatment CAPS score changes from MDMA-AT publications. حسب Filip Stanicic (17808254)

الموضوعات: